| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANTX | Common Stock | Sale | $5,376 | -336 | -0.02% | $16.00 | 2,177,547 | 13 Sep 2023 | Direct | F1, F2 |
| transaction | ANTX | Common Stock | Sale | $1,024 | -64 | -0.02% | $16.00 | 411,893 | 13 Sep 2023 | By Adjuvant Global Health Technology Fund DE, L.P.( | F1, F3 |
| Id | Content |
|---|---|
| F1 | The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022. |
| F2 | Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities. |
| F3 | Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities. |